The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 04, 2018
Filed:
Mar. 21, 2017
Applicant:
Glaxosmithkline Llc, Wilmington, DE (US);
Inventor:
Brian Alvin Johns, Research Triangle Park, NC (US);
Assignee:
GLAXOSMITHKLINE LLC, Wilmington, New Castle, DE (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/56 (2006.01); A61K 31/568 (2006.01); C07J 63/00 (2006.01); A61K 31/225 (2006.01); A61K 31/472 (2006.01); A61K 31/495 (2006.01); A61K 31/505 (2006.01); A61K 31/5375 (2006.01); A61K 31/54 (2006.01); A61K 31/551 (2006.01); A61K 45/06 (2006.01); C07D 217/04 (2006.01); C07D 239/26 (2006.01); C07D 243/08 (2006.01); C07D 265/32 (2006.01); C07C 219/24 (2006.01); C07C 225/14 (2006.01); A61K 31/222 (2006.01); A61K 31/4985 (2006.01); C07D 239/48 (2006.01); C07D 498/14 (2006.01); A61K 31/397 (2006.01); A61K 31/40 (2006.01); A61K 31/44 (2006.01); A61K 31/506 (2006.01); C07D 205/04 (2006.01); C07D 207/09 (2006.01); C07D 213/40 (2006.01); C07D 265/30 (2006.01); C07D 413/06 (2006.01); A61K 31/58 (2006.01); C07J 53/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/568 (2013.01); A61K 31/222 (2013.01); A61K 31/225 (2013.01); A61K 31/397 (2013.01); A61K 31/40 (2013.01); A61K 31/44 (2013.01); A61K 31/472 (2013.01); A61K 31/495 (2013.01); A61K 31/4985 (2013.01); A61K 31/505 (2013.01); A61K 31/506 (2013.01); A61K 31/5375 (2013.01); A61K 31/54 (2013.01); A61K 31/551 (2013.01); A61K 31/58 (2013.01); A61K 45/06 (2013.01); C07C 219/24 (2013.01); C07C 225/14 (2013.01); C07D 205/04 (2013.01); C07D 207/09 (2013.01); C07D 213/40 (2013.01); C07D 217/04 (2013.01); C07D 239/26 (2013.01); C07D 239/48 (2013.01); C07D 243/08 (2013.01); C07D 265/30 (2013.01); C07D 265/32 (2013.01); C07D 413/06 (2013.01); C07D 498/14 (2013.01); C07J 53/002 (2013.01); C07J 63/008 (2013.01); A61K 31/56 (2013.01); C07C 2601/02 (2017.05); C07C 2601/14 (2017.05); C07C 2603/52 (2017.05);
Abstract
The present invention relates to compounds characterized by having a structure according to the following Formula I: or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.